Inventor profile of:

David Cousin

City:

Nottingham

Country:

United Kingdom

Published Applications:

18

Last publication date:

2026-06-11

Top Assignees for applications by David Cousin

The entities that hold a legal rights for patent applications filed by inventor Cousin David:

Recent patent applications by Cousin David

David Cousin from Nottingham, GB has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-06-11
US20260159502A1
Chemistry; metallurgy

N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases

#2 | 2026-03-26
US20260085061A1
Chemistry; metallurgy

PHTHALAZINE DERIVATIVES AS PYRUVATE KINASE MODULATORS

#3 | 2025-07-17
US20250230143A1
Chemistry; metallurgy

PHTHALAZINE DERIVATIVES AS PYRUVATE KINASE MODULATORS

#4 | 2025-03-06
US20250074900A1
Chemistry; metallurgy

ISOINDOLINONE INHIBITORS OF THE MDM2-P53 INTERACTION AND PROCESS FOR MAKING THEM

#5 | 2024-11-07
US20240368136A1
Chemistry; metallurgy

BENZOLACTAM COMPOUNDS AS PROTEIN KINASE INHIBITORS

#6 | 2023-09-07
US20230278989A1
Chemistry; metallurgy

Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them

#7 | 2023-07-13
US20230219907A1
Chemistry; metallurgy

CARBOXY DERIVATIVES WITH ANTIINFLAMATORY PROPERTIES

#8 | 2023-06-22
US20230192673A1
Chemistry; metallurgy

Compounds

#9 | 2023-01-19
US20230019032A1
Chemistry; metallurgy

Benzolactam compounds as protein kinase inhibitors

#10 | 2022-10-13
US20220324837A1
Chemistry; metallurgy

N-(5-(6-ethoxypyrazin-2-yl)pyridin-2-yl)-4-(2-(methylsulfonamido)pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases

#11 | 2022-08-25
US20220265595A1
Human necessities

ITACONIC ACID DERIVATIVES AND USES THEREOF INTREATING AN INFLAMMATORY DISEASE OR A DISEASE ASSOCIATED WITH AN UNDESIRABLE IMMUNE RESPONSE

#12 | 2021-04-08
US20210101887A1
Chemistry; metallurgy

Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them

#13 | 2021-01-07
US20210002269A1
Chemistry; metallurgy

Aminothiazole compounds as inhibitors of CTPS1

#14 | 2019-02-14
US20190047990A1
Chemistry; metallurgy

Benzolactam compounds as protein kinase inhibitors

#15 | 2018-05-10
US20180127402A1
Chemistry; metallurgy

Isoxazolyl substituted benzimidazoles

#16 | 2013-11-21
US20130310411A1
Chemistry; metallurgy

NOVEL ACRIDINE DERIVATIVES

#17 | 2013-01-10
US20130012706A1
Chemistry; metallurgy

Methods and Intermediates for the Synthesis of 4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5]tetrazines

#18 | 2012-04-05
US20120083513A1
Chemistry; metallurgy

3-substituted-8-substituted-3H-imidazo[5,1-d][1,2,3,5]tetrazin-4-one compounds and their use

InventorID:

30601 ⎘